Professional Seasonal Analysis for Trading

CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI)

Seasonality Analysis

Stocks 27 Years Analyzed

CASI Pharmaceuticals, Inc. - Ordinary Shares Annual Seasonality Statistics

-3.74%
Avg Annual Return
36.0%
Avg Monthly Win Rate
3/12
Positive Months
27
Years Analyzed

CASI Pharmaceuticals, Inc. - Ordinary Shares Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January BEST 11.14%
59%
Moderate
February -3.17%
33%
Very Weak
March -2.10%
30%
Very Weak
April 3.71%
41%
Weak
May -0.12%
27%
Very Weak
June -5.59%
35%
Very Weak
July -3.51%
31%
Very Weak
August -0.01%
27%
Very Weak
September -2.51%
38%
Very Weak
October 9.80%
62%
Strong
November -0.81%
35%
Very Weak
December WORST -10.57%
15%
Very Weak

CASI Pharmaceuticals, Inc. - Ordinary Shares 2026 vs Historical Pattern

Current Position
1.11
Historical Avg Position
36.51
Deviation
-35.4
Performance
Significantly Below Average

CASI Pharmaceuticals, Inc. - Ordinary Shares Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for CASI with overlay patterns, custom date ranges, and more.

Create Free Account

CASI Pharmaceuticals, Inc. - Ordinary Shares Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

CASI Pharmaceuticals, Inc. - Ordinary Shares Seasonal Historical Performance

Historical Performance

See historical average returns for CASI across multiple timeframes.

Create Free Account

About CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI) Seasonality

CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI) has been analyzed using 27 years of historical data to identify seasonal patterns. Classified under Stocks, CASI Pharmaceuticals, Inc. - Ordinary Shares shows distinct seasonal tendencies based on historical data.

The strongest month for CASI Pharmaceuticals, Inc. - Ordinary Shares is historically January, with an average return of 11.14% and a win rate of 59%. Conversely, December tends to be the weakest month, averaging -10.57% return.

Looking at the full calendar year, CASI Pharmaceuticals, Inc. - Ordinary Shares has an average annual return of -3.74% with an overall monthly win rate of 36.0%. Out of 12 months, 3 typically show positive average returns.

The seasonal pattern for CASI Pharmaceuticals, Inc. - Ordinary Shares has a consistency score of 41.8 (Poor), based on 27 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

CASI Pharmaceuticals, Inc. - Ordinary Shares Seasonality FAQ

What is the best month to buy CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI)?

Historically, January has been the best month for CASI Pharmaceuticals, Inc. - Ordinary Shares, with an average return of 11.14% and a win rate of 59%. However, past performance does not guarantee future results.

What is the worst month for CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI)?

Based on historical data, December has been the weakest month for CASI Pharmaceuticals, Inc. - Ordinary Shares, with an average return of -10.57%. This is a historical observation and does not guarantee future results.

How reliable is CASI seasonality data?

The seasonality analysis for CASI Pharmaceuticals, Inc. - Ordinary Shares is based on 27 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use CASI Pharmaceuticals, Inc. - Ordinary Shares seasonality in my trading?

Use CASI Pharmaceuticals, Inc. - Ordinary Shares (CASI) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.